S. Colli
- Nutrition and Dietetics top 1%
- Fatty Acid Research and Health 18
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 8
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 8
- Internal Medicine top 5%
-
- Antiplatelet Therapy and Cardiovascular Diseases 34
-
- Inflammatory mediators and NSAID effects 23
-
- Lipoproteins and Cardiovascular Health 17
- Cholesterol and Lipid Metabolism 10
-
- Peroxisome Proliferator-Activated Receptors 6
S. Colli
101 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 113
- Nutrition and Dietetics 648
- Biochemistry 273
- Hematology 341
- Internal Medicine 114
- Cardiology and Cardiovascular Medicine 597
Countries citing papers authored by S. Colli
This map shows the geographic impact of S. Colli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Colli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Colli more than expected).
Fields of papers citing papers by S. Colli
This network shows the impact of papers produced by S. Colli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Colli. The network helps show where S. Colli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Colli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 22 | |
| 2 | 2012 | 7 | |
| 3 | 2011 | 33 | |
| 4 | 2010 | 36 | |
| 5 | 2008 | 23 | |
| 6 | 2007 | 141 | |
| 7 | 2005 | 28 | |
| 8 | 2004 | 46 | |
| 9 | 2004 | 143 | |
| 10 | 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. | 2002 | 34 |
| 11 | Vastatins inhibit tissue factor expression by human macrophages. | 1997 | 1 |
| 12 | 1996 | 13 | |
| 13 | 1995 | 47 | |
| 14 | 1993 | 9 | |
| 15 | 1993 | 114 | |
| 16 | 1993 | 24 | |
| 17 | 1991 | 11 | |
| 18 | 1990 | 29 | |
| 19 | 1988 | 6 | |
| 20 | 1988 | 13 |
About S. Colli
S. Colli is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Biochemistry, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (34 papers), Inflammatory mediators and NSAID effects (23 papers), Fatty Acid Research and Health (18 papers), Lipoproteins and Cardiovascular Health (17 papers), Cholesterol and Lipid Metabolism (10 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). The work is most often cited by research in Nutrition and Dietetics (648 citations), Biochemistry (273 citations) and Hematology (341 citations). S. Colli has collaborated with scholars based in Italy, United States and Lebanon. Frequent co-authors include Elena Tremoli, Sonia Eligini, Marina Camera, P. Maderna, C. Galli, Cesare R. Sirtori, Rodolfo Paoletti, Silvia Stella Barbieri, Marta Brambilla and Vincenzo Toschi. Their work appears in journals such as Thrombosis and Haemostasis, Atherosclerosis, Biochemical Pharmacology, Pharmacological Research and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.